RXRX EBITDA Margin

Recursion Pharmaceuticals Inc Clas · EBITDA Margin

RXRX logo

RXRX EBITDA Margin

Latest reported-810.22%
RXRX EBITDA Margin (-3471.07% → -810.22%)
High-resolution chart · PNG

RXRX ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Recursion Pharmaceuticals Inc Clas EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-749.0312%
-725.2367%
-701.1327%
-573.7381%
-1,751.22%
-2,393.8764%
-3,471.0695%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.